Showing results (1-10 of 58) with videos related to
Sort By:
Pageof 6
Scandinavian Journal of Urology and Nephrology. Supplementum|July 5, 2003
Neuroendocrine differentiation in prostatic carcinomaJens Hansson, Per-Anders AbrahamssonThe Prostate|September 5, 2002
Expression of somatostatin receptor subtypes 2 and 4 in human benign prostatic hyperplasia and prostatic cancerJens Hansson, Anders Bjartell, Virgil Gadaleanu, et al.Asian Journal of Urology|February 2, 2018
Intermittent androgen deprivation therapy in patients with prostate cancer: Connecting the dotsPer-Anders AbrahamssonEuropean Urology|August 18, 2009
Potential benefits of intermittent androgen suppression therapy in the treatment of prostate cancer: a systematic review of the literaturePer-Anders AbrahamssonFrontiers of Radiation Therapy and Oncology|June 12, 2008
Prostate cancer and active surveillancePer-Anders AbrahamssonUrologic Oncology|December 12, 2002
Localization and mRNA expression of somatostatin receptor subtypes in human prostatic tissue and prostate cancer cell linesNishtman Dizeyi, Lutz Konrad, Anders Bjartell, et al.The Journal of Urology|January 25, 2003
Prostate specific antigen and human glandular kallikrein 2 in early detection of prostate cancerGuram Karazanashvili, Per-Anders AbrahamssonEuropean Urology|January 22, 2005
Neuroendocrine differentiation in prostate cancer: implications for new treatment modalitiesNadezda Vashchenko, Per-Anders AbrahamssonEuropean Urology|June 17, 2008
PSA-based screening for prostate cancer: how does it compare with other cancer screening tests?E David Crawford, Per-Anders AbrahamssonAsian Journal of Andrology|July 14, 2020
Androgen deprivation therapy and side effects: are GnRH antagonists safer?Stephen J Freedland, Per-Anders AbrahamssonPageof 6